A Review on Biological and Chemical Potential of Phthalimide and Maleimide Derivatives
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Polyurethane-Polybenzoxazine Based
POLYURETHANE-POLYBENZOXAZINE BASED SHAPE MEMORY POLYMERS A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Numan Erden December, 2009 POLYURETHANE-POLYBENZOXAZINE BASED SHAPE MEMORY POLYMERS Numan Erden Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Sadhan C. Jana Dr. Sadhan C. Jana _______________________________ _______________________________ Faculty Reader Dean of the College Dr. Kevin Cavicchi Dr. Stephen Z.D. Cheng _______________________________ _______________________________ Faculty Reader Dean of the Graduate School Dr. Robert A. Weiss Dr. George R. Newkome _______________________________ Date ii ABSTRACT Shape memory polyurethanes (SMPUs) have attracted much attention from academic and industrial researchers due to strong potential in biomedical and consumer applications. Some of the limiting factors of these materials are low recovery stress (RS) and shape recovery (SR). Fundamental studies have focused on the improvement of RS and SR values using primarily two approaches. The first utilizes the nanocomposite route by which a few weight percentages of nanofillers are added to SMPU in order to increase the modulus and consequently to obtain enhancement in recovery stress. Although successful in the case of SMPU with amorphous soft segments, the nanofillers caused reduction in crystallinity of crystalline soft segment leading to deterioration of shape memory properties of SMPUs. In the second approach, chemical additives are added which either chemically bond with SMPU chains or form a separate phase and offer much stronger modulus than the soft and hard segments of SMPU. This second approach was followed in the current study. Polybenzoxazine (PB-a) was incorporated into a thermoplastic polyurethane (PU) formulation, anticipating that it would play a similar role to hard segment and improve the shape memory properties. -
Exploiting Protected Maleimides to Modify Oligonucleotides, Peptides and Peptide Nucleic Acids
Molecules 2015, 20, 6389-6408; doi:10.3390/molecules20046389 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Exploiting Protected Maleimides to Modify Oligonucleotides, Peptides and Peptide Nucleic Acids Clément Paris †, Omar Brun †, Enrique Pedroso and Anna Grandas * Departament de Química Orgànica i IBUB, Facultat de Química, Universitat de Barcelona, Martí i Franquès 1-11, 08028 Barcelona, Spain; E-Mails: [email protected] (C.P.); [email protected] (O.B.); [email protected] (E.P.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +34-934-021-263. Academic Editor: Scott Reed Received: 12 February 2015 / Accepted: 31 March 2015 / Published: 10 April 2015 Abstract: This manuscript reviews the possibilities offered by 2,5-dimethylfuran-protected maleimides. Suitably derivatized building blocks incorporating the exo Diels-Alder cycloadduct can be introduced at any position of oligonucleotides, peptide nucleic acids, peptides and peptoids, making use of standard solid-phase procedures. Maleimide deprotection takes place upon heating, which can be followed by either Michael-type or Diels-Alder click conjugation reactions. However, the one-pot procedure in which maleimide deprotection and conjugation are simultaneously carried out provides the target conjugate more quickly and, more importantly, in better yield. This procedure is compatible with conjugates involving oligonucleotides, peptides and peptide nucleic acids. A variety of cyclic peptides and oligonucleotides can be obtained from peptide and oligonucleotide precursors incorporating protected maleimides and thiols. Keywords: protected maleimides; oligonucleotides; peptides; conjugates; cyclization Molecules 2015, 20 6390 1. Introduction. Maleimide-Involving Click Conjugation Reactions with Oligonucleotides and Polyamides The Michael-type addition of thiols to electron deficient carbon-carbon double bonds is one of the oldest click reactions [1]. -
Exploring Maleimide-Based Nanoparticle Surface Engineering to Control Cellular Interactions # # Joanne C
www.acsanm.org Article Exploring Maleimide-Based Nanoparticle Surface Engineering to Control Cellular Interactions # # Joanne C. Lee, Nathan D. Donahue, Angelina S. Mao, Amber Karim, Mallikharjuna Komarneni, Emily E. Thomas, Emmy R. Francek, Wen Yang, and Stefan Wilhelm* Cite This: https://dx.doi.org/10.1021/acsanm.9b02541 Read Online ACCESS Metrics & More Article Recommendations *sı Supporting Information ABSTRACT: Nanoparticle cellular interactions are governed by nanoparticle surface chemistry and the surface display of functional (bio)molecules. To conjugate and display thiol-containing (bio)- molecules on nanoparticle surfaces, reactions between thiols and functional maleimide groups are often exploited. However, current procedures for modifying nanoparticle surfaces with maleimide groups are complex and can result in nanoparticle aggregation. Here, we demonstrate a straightforward, fast (∼30 min), efficient, and robust one-step surface engineering protocol for modifying gold nanoparticles with functional maleimide groups. We designed a hetero-bifunctional poly(ethylene glycol)-based molecule that attaches efficiently to the gold nanoparticle surface in a single step via its orthopyridyl disulfide (OPSS) terminal end, leaving its maleimide functional group available for downstream reaction with thiols. Using this surface engineering approach, we fabricated gold nanoparticles with near neutral and positive surface charges, respectively. We demonstrate that nanoparticle cellular uptake efficiencies in model mouse breast cancer (4T1) cells, -
Preparative Method of Novel Phthalocyanines from 3- Nitro
Available online a t www.derpharmachemica.com Scholars Research Library Der Pharma Chemica, 2012, 4(4):1397-1403 (http://derpharmachemica.com/archive.html) ISSN 0975-413X CODEN (USA): PCHHAX Preparative Method of Novel Phthalocyanines from 3- Nitro Phthalic Anhydride, Cobalt salt and Urea with Chloromethylpolyestyrene as a Heterogenous, Reusable and Efficient Catalyst Mohammad Ali Zolfigol 2, Ali Reza Pourali 1, Sami Sajjadifar 3,4 and Shohreh Farahmand 1,2,4 1Faculty of Chemistry, Bu-Ali Sina University, Hamedan, P.O. Box 6517838683, Iran 2School of Chemistry, Damghan University, Damghan, Iran 3Department of Chemistry, Faculty of Science, Ilam University, P.O. Box 69315516, Ilam, Iran 4Department of Chemistry, Payame Noor University, Tehran, P.O. Box 19395-4697, Iran _____________________________________________________________________________________________ ABSTRACT 3-Nitrophthalic anhydride was reacted with urea and cobalt salt in nitrobenzene under N 2 at 185°C and cobalt- tetraanitrophthalocyanine (CoTNP) was produced. Cobalt-tetraaminophthalocyanine (CoTAP) was produced by reduction of CoTNP caused by Sodium borohydride under N 2(g). CoTAP and chloromethylpolystyrene was refluxed in nitrobenzene or DMF at 180 oC for 12h. The mixture was cooled down to reach the room temperature and then solvent removed and the resulting precipitate was washed with water to remove excess CoTAP, and dried it to get a light green solid (CoTAP-linked-polymer). Kaywords Phthalocyanines, Cobaltetraminophthalocyanine, CoTAP ,Phthalocyanines linked polymer. _____________________________________________________________________________________________ INTRODUCTION Phthalocyanines are of interest not only as model compounds for the biologically important porphyrins but also because the intensely colored metal complexes are of commercial importance as dyes and pigments [1], the copper derivatives being an important blue pigment [2]. -
SMCC, Ssmcc, Lc-SMCC
FT-17412A SMCC, sSMCC, lc-SMCC Heterobifunctionnal crosslinkers Products Description Catalog number: UP17412A, 100mg UP17412B, 50mg Name: Sulfo-SMCC Formula : 4-(N-maleimidomethyl)cyclohexane-1-carboxylic 3- sulfo-n-hydroxysuccinimide ester [Syn.: sSMCC, Water-Soluble SMCC] CAS: 92921-24-9 , MW= 436.3 Catalog number: UP34253A, 50mg UP34253B, 100mg Name: SMCC Formula : Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1- carboxylate CAS: 64987-85-5 , MW= 334.3 Catalog number: L7739A, 50mg L7739B, 100mg L7739, 250mg Name: LC-SMCC Formula : Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1- carboxy-(3-AmidoCaproate) [syn.: Long-Chain SMCC] CAS: 64987-85-5 , MW= 447.5 Spacer is 16.1A long (16 atoms) Storage : -20°C (possible at +4°C) (M), protect from moisture and light. General Considerations SMCC is an popular heterobifunctional crosslinking agent. It contains 2 reactivities that allow the conjugation of molecules in a defined manner, avoiding notably the formation of dimers and polymers: . a succinimidyl ester group, that reacts on target amines of a moleucle1 (a protein, or an amino-nucleotide) . a maleimidyl group, that reactos on target sulfhydryl group of molecule2 (i.e. a reduce protein or Cys-peptides) Uptima provides a high quality SMCC to answer the needs of coupling proteins and peptides for biological and immunoassays like (other crosslinkers are available): - Preparation of immunogens carrier-hapten - Preparation of labeled affine probes: for example, antibodies coupled to enzyme for immunoblotting, fluorophore-peptides conjugates for the study of receptors, enzyme-drugs for using as tracers in ELISA… - Preparation of oligomeric conjugates: conjugates of oriented peptides for immunization, dimeric proteins for structural studies, grafting haptens onto cells… - Preparation of biologically active conjugates: specific antibody coupled to drugs for immunotargetting techniques, immunotoxins, … Ask for other crosslinkers similar to SMCC that are available from Uptima (see related products). -
Optimization of a Pegylated Glucuronide-Monomethylauristatin E Linker For
Author Manuscript Published OnlineFirst on November 9, 2016; DOI: 10.1158/1535-7163.MCT-16-0343 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Optimization of a PEGylated glucuronide-monomethylauristatin E linker for antibody-drug conjugates Patrick J. Burke, Joseph Z. Hamilton, Scott C. Jeffrey, Joshua H. Hunter, Svetlana O. Doronina, Nicole M. Okeley, Jamie B. Miyamoto, Martha E. Anderson, Ivan J. Stone, Michelle L. Ulrich, Jessica K. Simmons, Erica E. McKinney, Peter D. Senter, and Robert P. Lyon Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, WA 98021 Running title: Optimized glucuronide-monomethylauristatin E linker for ADCs Keywords: antibody-drug conjugates, auristatin, drug-linker, PEGylation, pharmacokinetics Corresponding author: Patrick J. Burke, Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, WA 98021. Phone: 425-527-4766; Fax: 425-527-4109; Email: [email protected] Conflict of interest statement: The authors disclose no potential conflicts of interest. Word count: 5309 words # figures/tables: 7 1 Downloaded from mct.aacrjournals.org on September 27, 2021. © 2016 American Association for Cancer Research. Author Manuscript Published OnlineFirst on November 9, 2016; DOI: 10.1158/1535-7163.MCT-16-0343 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract The emergence of antibody-drug conjugates (ADCs) such as brentuximab vedotin and ado- trastuzumab emtansine has led to increased efforts to identify new payloads and develop improved drug-linker technologies. Most antibody payloads impart significant hydrophobicity to the ADC, resulting in accelerated plasma clearance and suboptimal in vivo activity, particularly for conjugates with high drug-to-antibody ratios (DAR). -
Phthaloyl Amino Acids As Anti-Inflammatory And
MEDICINAL Med Chem Res (2014) 23:1701–1708 CHEMISTRY DOI 10.1007/s00044-013-0730-1 RESEARCH ORIGINAL RESEARCH Phthaloyl amino acids as anti-inflammatory and immunomodulatory prototypes Ana Cristina Lima Leite • Fa´bio Fernandes Barbosa • Marcos Verı´ssimo de Oliveira Cardoso • Diogo R. M. Moreira • Lucas Cunha D. Coeˆlho • Elany Barbosa da Silva • Gevanio Bezerra de Oliveira Filho • Valdeˆnia Maria Oliveira de Souza • Vale´ria Reˆgo A. Pereira • Luiza de C. Reis • Paulo Michel Pinheiro Ferreira • Claudia Pessoa • Almir Gonc¸alves Wanderley • Fernanda Virgı´nia B. Mota • Teresinha G. da Silva Received: 7 May 2013 / Accepted: 15 August 2013 / Published online: 12 September 2013 Ó Springer Science+Business Media New York 2013 Abstract A series of phthalimide analogs were synthesized Introduction by derivatization of phthalic anhydride, a highly toxic sub- stance, using a ‘‘one pot’’ condensation reaction to a-amino It is well known that the free radicals formed during acids. All phthaloyl amino acid derivatives presented anti-oral inflammation play an important role in killing the micro- inflammatory activity, but compounds 2e and 2g were found organism and activating leukocytes and macrophages. to possess the best activities comparable to thalidomide. Most Overproduction of these radicals is associated with a wide of the compounds effectively suppressed nitric oxide pro- range of pathological conditions (Ariel and Serhan, 2007; duction in murine cells stimulated with lipopolysaccharide. N- Nathan, 2002). Thus, it is important to develop anti- phthaloyl amino acids did not exhibit any significant cyto- inflammatory and immunomodulatory drugs that could toxicity in vitro when tested against tumor cells as well as a regulate the overproduction of these undesirable species spleen cell culture of BALB/c mice. -
A Rapid Crosslinkable Maleimide-Modified Hyaluronic
gels Article A Rapid Crosslinkable Maleimide-Modified Hyaluronic Acid and Gelatin Hydrogel Delivery System for Regenerative Applications Kyung Min Yoo 1, Sean V. Murphy 1,* and Aleksander Skardal 2,3,* 1 Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, 391 Technology Way, Winston-Salem, NC 27101, USA; [email protected] 2 Department of Biomedical Engineering, The Ohio State University, Fontana Labs., 140 W. 19th Ave, Columbus, OH 43210, USA 3 Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, OH 43210, USA * Correspondence: [email protected] (S.V.M.); [email protected] (A.S.) Abstract: Hydrogels have played a significant role in many applications of regenerative medicine and tissue engineering due to their versatile properties in realizing design and functional requirements. However, as bioengineered solutions are translated towards clinical application, new hurdles and subsequent material requirements can arise. For example, in applications such as cell encapsulation, drug delivery, and biofabrication, in a clinical setting, hydrogels benefit from being comprised of natural extracellular matrix-based materials, but with defined, controllable, and modular properties. Advantages for these clinical applications include ultraviolet light-free and rapid polymerization crosslinking kinetics, and a cell-friendly crosslinking environment that supports cell encapsulation or in situ crosslinking in the presence of cells and tissue. Here we describe the synthesis and charac- terization of maleimide-modified hyaluronic acid (HA) and gelatin, which are crosslinked using a bifunctional thiolated polyethylene glycol (PEG) crosslinker. Synthesized products were evaluated by proton nuclear magnetic resonance (NMR), ultraviolet visibility spectrometry, size exclusion chro- Citation: Yoo, K.M.; Murphy, S.V.; matography, and pH sensitivity, which confirmed successful HA and gelatin modification, molecular Skardal, A. -
Recent Advances and Future Prospects of Phthalimide Derivatives
Journal of Applied Pharmaceutical Science Vol. 6 (03), pp. 159-171, March, 2016 Available online at http://www.japsonline.com DOI: 10.7324/JAPS.2016.60330 ISSN 2231-3354 Recent Advances and Future Prospects of Phthalimide Derivatives Neelottama Kushwahaa*, Darpan Kaushikb aPranveer Singh Institute of Technology, Kanpur, India. bPrasad Institute of Technology, Jaunpur, India. ABSTRACT ARTICLE INFO Article history: Among bicyclic non-aromatic nitrogen heterocycles, phthalimides are an interesting class of compounds with a Received on: 21/05/2015 large range of applications. Phthalimide contains an imide functional group and may be considered as nitrogen Revised on: 13/09/2015 analogues of anhydrides or as diacyl derivatives of ammonia. They are lipophilic and neutral compounds and can Accepted on: 02/11/2015 therefore easily cross biological membranes in vivo and showing different pharmacological activities. In the Available online: 10/03/2016 present work compounds containing phthalimide subunit have been described as a scaffold to design new prototypes drug candidates with different biological activities and are used in different diseases as, for example Key words: AIDS, tumor, diabetes, multiple myeloma, convulsion, inflammation, pain, bacterial infection among others. Phthalimide derivatives, imide, biological activity. INTRODUCTION have served as starting materials and intermediates for the synthesis of many types of alkaloids and pharmacophores. Phthalimides possess a structural feature –CO-N(R)- CO- and an imide ring which help them to be biologically active Structure of Phthalimide and pharmaceutically useful. Phthalimides have received attention due to their androgen receptor antagonists (Sharma et Phthalimide is an imido derivative of phthalic acid. In al., 2012), anticonvulsant (Kathuria and Pathak, 2012), organic chemistry, imide is a functional group consisting of two antimicrobial (Khidre et al., 2011), hypoglycaemic (Mbarki and carbonyl groups bound to nitrogen. -
United States Patent to 11 B 4,001,273 Hetzel Et Al
United States Patent to 11 B 4,001,273 Hetzel et al. 45 Jan. 4, 1977 54 CONTINUOUS MANUFACTURE OF 56 References Cited PHTHALIMIDE UNITED STATES PATENTS (75) Inventors: Eckhard Hetzel; Ludwig Vogel, both 2,566,992 9/1951 Morgan et al. ................ 260/326 R of Frankenthal; Gerhard Rotermund, Heidelberg; Hans FOREIGN PATENTS OR APPLICATIONS Christoph Horn, Lambsheim, all of 300,770 8/1972 Austria .......................... 260/326 R Germany OTHER PUBLICATIONS 73) Assignee: BASF Aktiengesellschaft, Pfeifer et al., “Chem. Abstracts," vol. 77, p. 353, No. Ludwigshafen (Rhine), Germany 126,087s (1972). 22 Filed: July 8, 1974 Primary Examiner-Elbert L. Roberts Assistant Examiner-S. P. Williams 21 ) Appl. No.: 486,678 Attorney, Agent, or Firm-Johnston, Keil, Thompson & 44 Published under the second Trial Voluntary Shurtleff Protest Program on March 2, 1976 as document 57 ABSTRACT No. B 486,678. Continuous manufacture of phthalimide by reaction of 30) Foreign Application Priority Data phthalic anhydride with ammonia and washing the offgas with a melt containing phthalimide. The product July 10, 1973 Germany .......................... 233496 is a starting material for the manufacture of dyes, pesti 52) U.S.C. ........................................... 260/326 R cides and pigments, especially copper phthalocyanines. 51 Int. Cl........................................ C07D 209/.48 (58) Field of Search ................................ 260/326 R 7 Claims, No Drawings 4,001,273 1 2 from by-products and the proportion of phthalimide CONTINUOUS MANUFACTURE OF has been increased. Such an off-gas can be used with PHTHALIMIDE advantage for numerous syntheses; since the off-gas is conveniently trapped in aqueous alkali, for cxample in This application discloses and claims subject matter 5 sodium hydroxide solution, or potassium hydroxide described in German Patent Application No. -
Chemical Protein Modification Through Cysteine 3 4 4 5 Smita B
DOI: 10.1002/cbic.201500667 Reviews 1 1 2 2 3 Chemical Protein Modification through Cysteine 3 4 4 5 Smita B. Gunnoo and Annemieke Madder*[a] 5 6 6 7 7 8 8 9 9 10 10 11 11 12 12 13 13 14 14 15 15 16 16 17 17 18 18 19 19 20 20 21 21 22 22 23 23 24 24 25 25 26 26 27 27 28 28 29 29 30 30 31 31 32 32 33 33 34 34 35 35 36 36 37 37 38 38 39 39 40 40 41 41 42 42 43 43 44 44 45 45 46 46 47 47 48 48 49 49 50 50 51 51 52 52 53 53 54 54 55 55 56 56 57 57 ChemBioChem 2016, 17,2–27 2 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim ÝÝ These are not the final page numbers! Reviews 1 The modification of proteins with non-protein entities is impor- for site-selective modification, including a unique nucleophilici- 1 2 tant for a wealth of applications, and methods for chemically ty, and a low natural abundance—both allowing chemo- and 2 3 modifying proteins attract considerable attention. Generally, regioselectivity. Native cysteine residues can be targeted, or 3 4 modification is desired at a single site to maintain homogenei- Cys can be introduced at a desired site in a protein by means 4 5 ty and to minimise loss of function. Though protein modifica- of reliable genetic engineering techniques. This review on 5 6 tion can be achieved by targeting some natural amino acid chemical protein modification through cysteine should appeal 6 7 side chains, this often leads to ill-defined and randomly modi- to those interested in modifying proteins for a range of appli- 7 8 fied proteins. -
Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines
International Journal of Molecular Sciences Article Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines Ariana Abawi 1,†, Xiaoyi Wang 1,† , Julien Bompard 1, Anna Bérot 1, Valentina Andretto 2 , Leslie Gudimard 1, Chloé Devillard 1, Emma Petiot 1, Benoit Joseph 1, Giovanna Lollo 2, Thierry Granjon 1, Agnès Girard-Egrot 1 and Ofelia Maniti 1,* 1 Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, ICBMS UMR 5246, Univ Lyon, Université Lyon 1, CNRS, F-69622 Lyon, France; [email protected] (A.A.); [email protected] (X.W.); [email protected] (J.B.); [email protected] (A.B.); [email protected] (L.G.); [email protected] (C.D.); [email protected] (E.P.); [email protected] (B.J.); [email protected] (T.G.); [email protected] (A.G.-E.) 2 Laboratoire d’Automatique, de Génie des Procédés et de Génie Pharmaceutique, LAGEPP UMR 5007, Univ Lyon, Université Lyon 1, CNRS, F-69622 Lyon, France; [email protected] (V.A.); [email protected] (G.L.) * Correspondence: [email protected]; Tel.: +33-(0)4-72-44-82-14 † These authors have equally contributed to the manuscript. Abstract: Novel nanomedicines have been engineered to deliver molecules with therapeutic po- tentials, overcoming drawbacks such as poor solubility, toxicity or short half-life. Lipid-based carriers such as liposomes represent one of the most advanced classes of drug delivery systems. A Monomethyl Auristatin E (MMAE) warhead was grafted on a lipid derivative and integrated in Citation: Abawi, A.; Wang, X.; fusogenic liposomes, following the model of antibody drug conjugates.